In recent years, we have witnessed a renewed interest in psychedelic therapy and research being called “the psychedelic renaissance.” Many people are discovering the potential benefits of psychedelic substances and master plants, and shamanism has become an increasingly sought method for healing. Dozens of clinical trials study the efficacy of psychedelic medicines such as MDMA, psilocybin, and ketamine to treat serious conditions like PTSD and treatment-resistant depression. At the same time, the importance of Stanislav Grof’s Holotropic Paradigm and of Holotropic Breathwork® in the development of the psychedelic field still remains unknown to many.
With respect to this new era of psychedelics, those of us involved with the Holotropic paradigm have much to contribute and consider. How do psychedelics compare with or compliment Holotropic Breathwork® as tools for personal development? What is the role of Holotropic Breathwork® now that psychedelics are becoming an accessible therapeutic method? How is the future of Holotropic Breathwork® affected, now that more people can access deep experiences through psychedelics and master plants?
In this module we will explore in depth:
- The different paradigms in which psychedelics have been used, and are currently used.
- General characteristics of the main psychedelic medicines and the process they induce.
- The use of psychedelics from the Holotropic Paradigm developed by Grof, Sparks, and others.
- How do psychedelics compare to Holotropic Breathwork®?
- The principles of supporting processes from the Holotropic perspective.
- Dealing with challenging situations.
- The importance of integration of psychedelic experiences.
Cost for this module is 1260 Euro.
Cost is reduced for those from Poland, Ukraine, and other Eastern European countries; contact organizer for details.
Marc B. Aixalà (see full bio here)
is a GTT module leader trained in the therapeutic use of Non Ordinary States of Consciousness; in MDMA assisted-psychotherapy for PTSD by MAPS; and in the use of psilocybin for treatment-resistant depression. Marc works as a therapist and mentor in a clinical trial with psilocybin in Sant Joan de Déu Hospital in Barcelona. He has experience as a Team Leader and Trainer helping people through difficult psychedelic experiences at Boom Festival (Kosmicare 2010-2016).
Marc collaborates with ICEERS (International Center for Ethnobotanical Education Research and Service) by offering integration psychotherapy for people in challenging situations after psychedelic experiences, developing theoretical models of intervention and training and supervising therapists. He is the author of “Psychedelic Integration: non-ordinary logics and the challenges of psychotherapy in expanded states of awareness”.